AI-generated summary
The authors describe an ex vivo method called Laser Activated Nanothermolysis, in which antibody-targeted gold nanoparticles cluster on tumor cells and single laser pulses generate micro-bubbles to destroy them. In laboratory experiments with K562 and human lymphoblastic leukemia cells, the authors report complete elimination of targeted cells, with less damage to normal stem cells. The study is limited to cell suspensions outside the body.
- Who or what was studied
- Cell suspensions: K562 leukemia cells, human lymphoblastic leukemia cells, and normal stem cells (ex vivo)
- Wavelengths
- 532 nm
- Limits stated in the abstract
- The abstract reports only ex vivo cell experiments and does not describe any in vivo or clinical testing.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 532 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.